111 related articles for article (PubMed ID: 5964528)
1. [Chemotherapy of stomach cancer-with special reference to massive and intermittent administration of mitomycin C].
Matsunaga F; Shimoyama T; Mikawa K; Ishiwata J; Kikuchi H
Naika; 1966 Jun; 17(6):1101-15. PubMed ID: 5964528
[No Abstract] [Full Text] [Related]
2. [Prolonged intra-arterial administration of antineoplastic agents after surgery of stomach cancer. Suggestion for massive intermittent administration over a long period].
Honda K; Koseki M; Shiota Y; Kawamura T; Okuyama T
Gan No Rinsho; 1969 Mar; 15(3):327-31. PubMed ID: 5816308
[No Abstract] [Full Text] [Related]
3. [Combined application of drugs in cancer chemotherapy with special reference to the combination of mitomycin C, 5-fluorouracil, and cytosine arabinoside].
Nakao I; Furue H; Furukawa K; Kanko T; Harashima S
Gan No Rinsho; 1972 Feb; 18(2):138-43. PubMed ID: 5063156
[No Abstract] [Full Text] [Related]
4. [Case of unresectable gastric cancer for wich splenectomy was performed because massive administration of mitomycin C did not reduce the number of leukocytes].
Ono K; Shimano M
Gan No Rinsho; 1968 Oct; 14(10):874-8. PubMed ID: 5750972
[No Abstract] [Full Text] [Related]
5. [Clinical study of 47 patients with stomach cancer treated with mitomycin C].
Paolucci R
Cancro; 1971; 24(3):153-9. PubMed ID: 4949673
[No Abstract] [Full Text] [Related]
6. [Effect of mitomycin C on human gastric and colon carcinomas serially transplanted to nude mice--with special reference to the start of drug administration].
Kubota T; Hanatani Y; Tsuyuki K; Nakada M; Asanuma F; Ishibiki K; Abe O
Gan To Kagaku Ryoho; 1982 Apr; 9(4):638-45. PubMed ID: 6820902
[TBL] [Abstract][Full Text] [Related]
7. [Cancer chemotherapy in the field of surgery--with special reference to stomach cancer].
Hattori T; Niimoto M; Oride M
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1041-9. PubMed ID: 6408996
[TBL] [Abstract][Full Text] [Related]
8. [Pre-operative chemotherapy of stomach cancer combined with local administration of OK-432--evaluation of macroscopic results].
Mukai M; Den N; Yamazaki Y; Namiki S; Oda S; Nagao K
Gan To Kagaku Ryoho; 1982 Jan; 9(1):96-102. PubMed ID: 6820880
[TBL] [Abstract][Full Text] [Related]
9. [Administration of large doses of mitomycin C during stomach cancer surgery. Postoperative survival rates following palliative resection].
Hattori T; Ito I; Hirata K; Iizuka T; Abe K
Gan No Rinsho; 1965 Nov; 11(12):817-26. PubMed ID: 5894619
[No Abstract] [Full Text] [Related]
10. [Chemotherapy of gastrointestinal cancer in elderly patients--evaluation of combination therapy with mitomycin C and 5-fluorouracil].
Fujii M; Murakami N; Matsuka Y; Ejiri T; Asano K
Gan No Rinsho; 1983 Feb; 29(2):A-8, 129-32. PubMed ID: 6308301
[TBL] [Abstract][Full Text] [Related]
11. [Studies on the prevention of side-effects of the anti-cancer agent, mitomycin C by xylitol].
Iwasa H; Takahashi M
Gan No Rinsho; 1968 Jul; 14(7):561-5. PubMed ID: 5749780
[No Abstract] [Full Text] [Related]
12. [Combination chemotherapy of advanced gastric cancer with adriamycin, mitomycin C, and ftorafur].
Miyamoto H; Ogawa M; Inagaki J; Horikoshi N; Ezaki K; Inoue K; Ikeda K; Usui N; Nakada H; Okada Y
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1160-4. PubMed ID: 6408998
[TBL] [Abstract][Full Text] [Related]
13. Randomized comparison of 5-FU alone or combined with mitomycin and cytarabine (MFC) in the treatment of advanced gastric cancer.
Cocconi G; DeLisi V; Di Blasio B
Cancer Treat Rep; 1982 Jun; 66(6):1263-6. PubMed ID: 7083233
[TBL] [Abstract][Full Text] [Related]
14. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas.
Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS
Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051
[TBL] [Abstract][Full Text] [Related]
15. [Randomized study on the long-term adjuvant chemotherapy with ftorafur and mitomycin C for stomach cancer: second report].
Abe O; Inokuchi K; Hattori T; Inoue K; Taguchi T; Kondo T; Akiyama H; Ito I; Nakajima T; Muto T
Gan To Kagaku Ryoho; 1983 Nov; 10(11):2408-17. PubMed ID: 6416184
[TBL] [Abstract][Full Text] [Related]
16. Combined nonsimultaneous radiation therapy and chemotherapy with 5-FU, doxorubicin, and mitomycin for residual localized gastric adenocarcinoma: a Southwest Oncology Group pilot study.
Haas CD; Mansfield CM; Leichman LP; Considine B; Bukowski RM
Cancer Treat Rep; 1983 May; 67(5):421-4. PubMed ID: 6687837
[No Abstract] [Full Text] [Related]
17. [Chemotherapy of stomach cancer].
Gropp C; Havemann K
Z Gastroenterol; 1982 Dec; 20(12):703-9. PubMed ID: 6819730
[TBL] [Abstract][Full Text] [Related]
18. [Combined administration of mitomycin C for the improved management of stomach neoplasms].
Kakuta H; Kikuchi A; Nagano S; Machida S; Fukushima M; Ishikawa Y
Nihon Rinsho; 1978 Jun; 36(6):2576-80. PubMed ID: 359865
[No Abstract] [Full Text] [Related]
19. [Intra-arterial chemotherapy combined with noradrenaline--histopathological effect in stomach cancer].
Sato T; Sekine S; Katsumi S; Sato K; Kawaguchi T
Gan To Kagaku Ryoho; 1983 Jul; 10(7):1659-64. PubMed ID: 6409010
[TBL] [Abstract][Full Text] [Related]
20. [Experience of a combination chemotherapy consisting of 5-FU, MMC, and FT-207--side effects against kidney].
Yamada F; Kagami H; Fukutome A; Mastumine T; Miura T
Gan To Kagaku Ryoho; 1983 Sep; 10(9):2049-54. PubMed ID: 6412636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
